These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29477387)

  • 1. A Health Economics Approach to US Value Frameworks: Serving the Needs of Decision Making.
    Norman R; Chalkidou K; Culyer AJ
    Value Health; 2018 Feb; 21(2):117-118. PubMed ID: 29477387
    [No Abstract]   [Full Text] [Related]  

  • 2. ISPOR's Initiative on US Value Assessment Frameworks: A Missed Opportunity for ISPOR and Patients.
    Perfetto EM
    Value Health; 2018 Feb; 21(2):169-170. PubMed ID: 29477396
    [No Abstract]   [Full Text] [Related]  

  • 3. ISPOR's Initiative on US Value Assessment Frameworks: The Use of Cost-Effectiveness Research in Decision Making among US Insurers.
    Solow B; Pezalla EJ
    Value Health; 2018 Feb; 21(2):166-168. PubMed ID: 29477395
    [No Abstract]   [Full Text] [Related]  

  • 4. ISPOR's Initiative on US Value Assessment Frameworks: Seeking a Role for Health Economics.
    Sculpher M
    Value Health; 2018 Feb; 21(2):171-172. PubMed ID: 29477397
    [No Abstract]   [Full Text] [Related]  

  • 5. ISPOR's Initiative on US Value Assessment Frameworks: An Industry Perspective.
    Burkholder R; Dougherty JS; Neves LA
    Value Health; 2018 Feb; 21(2):173-175. PubMed ID: 29477398
    [No Abstract]   [Full Text] [Related]  

  • 6. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
    Garrison LP; Neumann PJ; Willke RJ; Basu A; Danzon PM; Doshi JA; Drummond MF; Lakdawalla DN; Pauly MV; Phelps CE; Ramsey SD; Towse A; Weinstein MC
    Value Health; 2018 Feb; 21(2):161-165. PubMed ID: 29477394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4].
    Danzon PM; Drummond MF; Towse A; Pauly MV
    Value Health; 2018 Feb; 21(2):140-145. PubMed ID: 29477391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2].
    Garrison LP; Pauly MV; Willke RJ; Neumann PJ
    Value Health; 2018 Feb; 21(2):124-130. PubMed ID: 29477389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].
    Willke RJ; Neumann PJ; Garrison LP; Ramsey SD
    Value Health; 2018 Feb; 21(2):155-160. PubMed ID: 29477393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health policy uses and usefulness of cost-benefit and cost-effectiveness analysis.
    Warner KE
    Mead Johnson Symp Perinat Dev Med; 1982; (20):53-69. PubMed ID: 6821470
    [No Abstract]   [Full Text] [Related]  

  • 11. A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1].
    Neumann PJ; Willke RJ; Garrison LP
    Value Health; 2018 Feb; 21(2):119-123. PubMed ID: 29477388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3].
    Lakdawalla DN; Doshi JA; Garrison LP; Phelps CE; Basu A; Danzon PM
    Value Health; 2018 Feb; 21(2):131-139. PubMed ID: 29477390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insurance industry's role in reforming delivery.
    Dowling WL
    Front Health Serv Manage; 1992; 9(1):36-40. PubMed ID: 10120465
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive health care reform.
    J Burn Care Rehabil; 1992; 13(6):680-2. PubMed ID: 1469035
    [No Abstract]   [Full Text] [Related]  

  • 15. Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5].
    Phelps CE; Lakdawalla DN; Basu A; Drummond MF; Towse A; Danzon PM
    Value Health; 2018 Feb; 21(2):146-154. PubMed ID: 29477392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health economics: a beginner's guide.
    Thornton JG
    Br J Hosp Med; 1997 Dec; 58(11):547-50. PubMed ID: 10193467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not just about costs: the role of health economics in facilitating decision making in aged care.
    Ratcliffe J; Laver K; Couzner L; Cameron ID; Gray L; Crotty M
    Age Ageing; 2010 Jul; 39(4):426-9. PubMed ID: 20444804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Presidential Candidates: is health care policy a nonissue?
    Stubenrauch JM
    Am J Nurs; 2004 Sep; 104(9):33, 35-7. PubMed ID: 15365337
    [No Abstract]   [Full Text] [Related]  

  • 19. Health care reform--where are we and where should we be going?
    Ginzberg E
    N Engl J Med; 1992 Oct; 327(18):1310-2. PubMed ID: 1306654
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of public participation in decision-making process in healthcare system illustarted with an example of the development of American and Polish scope of health benefit basket.
    Kolasa K; Hermanowski T; Borek E
    Przegl Epidemiol; 2013; 67(4):661-6, 749-54. PubMed ID: 24741914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.